Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2012Journal of the National Comprehensive Cancer NetworkOpen Access

Ten Years of Progress in Renal Cell Carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

EJEric JonaschThe University of Texas MD Anderson Cancer Center
Robert J. Motzer
Robert J. MotzerUniversité Claude Bernard Lyon 1

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jonasch et al. (2012) studied this question.

synapsesocial.com/papers/6aace4bddefaaedc0aaab732https://doi.org/10.6004/jnccn.2012.0071
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma2002 · 1,507 citations
  2. 2Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma2007 · 4,813 citations
  3. 3Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma2002 · 610 citations
  4. 4Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial2010 · 2,495 citations
  5. 5Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study2009 · 2,165 citations